Business
Final Results
Final Results.
About this update from Batm Advanced Communications Ltd.
[{"type":"text","content":"\n \nRNS Number : 9560R BATM Advanced Communications Ld 06 March 2019 \n\n6 March 2019 \n \nBATM Advanced Communications Limited\n(\"BATM\" or the \"Group\")\n \nFinal Results 2018\n \nBATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces its final results for the year ended 31 December 2018.\n \nFinancial Summary \nStrong growth in 2018, combined with a substantially higher order book at year end, resulting in the Group anticipating full year 2019 revenue and EBITDA growth ahead of market expectations. \n· Group revenue of $119.6m (2017: $107.1m)\n· Gross profit of $34.5m (2017: $32.7m)\n· Gross margin of 28.8% (2017: 30.6%)\n· Cash from operating activities of $2.6m (2017: $0.1m)\n· Adj.* operating profit of $2.6m (2017: $0.1m**)\n· Adj. EBITDA of $4.9m (2017: $2.2m**)\n· Earnings per share of 0.09¢ (2017: 0.06¢)\n· As at 31 December 2018, the Group had cash and financial assets of $24.4m (30 June 2018: $23.3m; 31 December 2017: $24.0m) \n* Adjusted to exclude the amortisation of intangible assets.\n** The 2017 figures are adjusted to exclude the exceptional capital gain from the sale of a property.\n \nOperational Summary \nBio-Medical Division (52% of total revenue)\n· Revenue increased by 8.2% to $62.1m (2017: $57.4m)\n· Blended gross margin of 25.0% (2017: 25.8%)\n· Diagnostics Unit\no Launched new molecular biology diagnostics Adaltis product line, with first orders delivered \no Achieved first sales of new highly-compact metabolism testing analyser, Hemo One\no Advanced en...